BioEquin FT, injectable suspension for horses
Homepage Products Veterinary products BioEquin FT, injectable suspension for horses
A vaccine for active immunisation of horses against equine influenza to reduce clinical signs and viral excretion following infection with equine influenza and for active immunisation against tetanus.
| type of preparative: | Vaccines |
|---|---|
| target species animals: | Horse |
Content
One dose (1 ml) of vaccine contains:
Virus influenzae equorum inactivatum, strain:
A/Equi 2/Morava 95 (Eurasian type), H3N8 min. 5 log2 HIT1
A/Equi 2/Brno 08 (American type, subline Florida 2), H3N8 min. 5 log2 HIT1
Anatoxinum tetanicum purificatum min. 30 IU2
1Geometric mean of specific antibodies determined by haemagglutination inhibition test in guinea pig serum
2International units; titre of anti-toxin antibodies, induced after repeated vaccination of guinea pigs according to Ph. Eur., as determined using the ELISA method
Injectable suspension.White or yellowish to grey-brown suspension. Sediment forms when left standing, which disperses after shaking.
Target species
Horses.
Indications for use, specifying the target species
For active immunisation of horses over six months of age against equine influenza to reduce clinical signs and viral excretion following infection with equine influenza and for active immunisation against tetanus.
Onset of immunity for equine influenza strain A/Equi 2/Brno 08 demonstrated by challenge test and for equine influenza strain A/Equi 2/Morava 95 by serology.
The duration of immunity for both vaccination strains of equine influenza was demonstrated by serology.
Influenza:
Onset of immunity: 14 days after basic vaccination
Duration of immunity: 6 months after basic vaccination and at least 12 months after first revaccination (third dose of the vaccine).
Tetanus:
Onset of immunity: 14 after basic vaccination
Duration of immunity: 6 months after basic vaccination and at least 12 months after first revaccination (third dose of the vaccine).
Contraindications
None.
Special warnings for each target species
In case of an increase in infection pressure, revaccination for equine influenza is recommended at an interval of 6 months, for all horses at stud.
All horses at stud should be vaccinated in order to reduce infection pressure.
Before moving horses to another stud farm or other stables, or before a race or meet, at least basic vaccination is recommended, allowing 14 days to acquire the necessary immunity. At least basic vaccination is also recommended as part of quarantine for all unvaccinated horses brought to stud, allowing 14 days to acquire the necessary immunity.
It is recommended that sick horses with symptoms of respiratory disease be stabled and kept in isolation from healthy animals.
Adverse reactions (frequency and seriousness)
Very often a slight increase in temperature of up to 1 °C may be observed in connection with vaccination for a period of 1-3 days.
In very rare cases, an anaphylactic reaction may occur. In such a case, symptomatic treatment is required.
Use during pregnancy, lactation or lay
Can be used during pregnancy. The safety of the veterinary medicinal product has not been determined during lactation.
Interactions with other medicinal products and other forms of interaction
No information is available on the safety and efficacy of this vaccine when administered in conjunction with any other veterinary medicinal product. The decision to use this vaccine before or after any other veterinary medicinal product must be made on a case by case basis.
Amounts to be administered and administration route
Vaccination dose - 1 ml. The vaccine is administered by deep intramuscular injection.
The contents of the vial should be warmed to a temperature of 15 – 25 °C and shaken thoroughly before use.
Vaccination programme
Basic vaccination:
First vaccination from 6 months of age, second vaccination in 4 weeks.
Revaccination:
First revaccination 6 months after basic vaccination and further revaccination at intervals of 12 months.
Mares in foal are revaccinated in the last trimester of pregnancy, but no later than one month prior to scheduled delivery.
It is recommended that BioEquin FT not be used to revaccinate horses previously vaccinated with a vaccine from a different manufacturer or to revaccinate with a vaccine from a different manufacturer after using BioEquin FT. The exception is vaccines containing the same strains of equine influenza as BioEquin FT.
Withdrawal period
Zero days
Shelf life
Shelf life of the veterinary medicinal product as packaged for sale: 33 months.
Shelf life after first opening of multi-dose package: 10 hours.
Special precautions for storage
Store in a refrigerator (2 – 8 °C). Protect from frost. Protect from light. Store in a dry place.
Package sizes
2 x 1 dose, 10 x 1 dose
Not all pack sizes may be marketed.